SEC 13F Intelligence

M28 Capital Management LP / TGTX

M28 Capital Management LP’s Tg Therapeutics Inc Position

Does M28 Capital Management LP own Tg Therapeutics Inc (TGTX)? Yes — 88.4K shares worth $3M (+5.46% of its 13F portfolio) as of Q1 2026, down from 161.6K shares the prior filed quarter.

Position Value
$3M
Q1 2026
Shares
88.4K
% of Portfolio
+5.46%
Quarters Held
18
currently held

Position History TGTX

Reported value by quarter
Q4 ’21: $10MQ4 ’21Q1 ’22: $10MQ2 ’22: $3MQ3 ’22: $2MQ3 ’22Q4 ’22: $1MQ1 ’23: $5MQ2 ’23: $4MQ2 ’23Q3 ’23: $2MQ4 ’23: $4MQ1 ’24: $2MQ1 ’24Q2 ’24: $3MQ3 ’24: $4MQ4 ’24: $5MQ4 ’24Q1 ’25: $6MQ2 ’25: $6MQ3 ’25: $6MQ3 ’25Q4 ’25: $5MQ1 ’26: $3Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202688.4K$3M+5.46%
Q4 2025161.6K$5M+3.50%
Q3 2025161.6K$6M+8.58%
Q2 2025161.6K$6M+9.92%
Q1 2025161.6K$6M+8.73%
Q4 2024161.6K$5M+4.78%
Q3 2024161.6K$4M+4.15%
Q2 2024161.6K$3M+3.73%
Q1 2024161.6K$2M+1.82%
Q4 2023216.6K$4M+3.06%
Q3 2023216.6K$2M+2.08%
Q2 2023142.5K$4M+4.68%
Q1 2023339.5K$5M+5.77%
Q4 2022104.4K$1M+1.18%
Q3 2022338.8K$2M+2.09%
Q2 2022726.2K$3M+3.46%
Q1 20221.05M$10M+9.16%
Q4 2021527.0K$10M+7.82%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See M28 Capital Management LP’s full portfolio or all institutional holders of TGTX.